CCM
OMGA

CAAS Capital Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

CAAS Capital Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$189K – 1086
2021
Q3 		$189K Buy
+10,000
New +$192K ﹤0.01% 742

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

CAAS Capital Management's OMGA Position: Q4 2021 in Review

CAAS Capital Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2021, closing a stake of 10,000 shares — an estimated $189K sold.

CAAS Capital Management first reported a position in OMGA in Q3 2021 and held it in 1 quarter. The position peaked at $189K in Q3 2021. 45 funds tracked by Wall St. Rank hold OMGA as of Q4 2021.

  • CAAS Capital Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • CAAS Capital Management sold 10,000 Omega Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $189K.
  • CAAS Capital Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • CAAS Capital Management's Omega Therapeutics, Inc. Common Stock position peaked at $189K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2021.

Based on CAAS Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.